Ribonucleic acids (RNAs), which decode the genetic code stored in DNA and produce proteins, fold into diverse structures to govern fundamental biological processes in all life forms, including humans. Targeting disease-associated RNA structures with drug-like small molecules has been one of the gold standards for developing RNA-targeting drugs in the scientific field. Recently, a research team has developed a new type of RNA structure targeting tool to specifically recognize unusual four-strand RNA structures, which are associated with diseases such as cancer and neurological disorders.
More News
NATO is boosting AI and climate research as scientific diplomacy remains on ice
Mini-colon and brain ‘organoids’ shed light on cancer and other diseases
Whole-cortex in situ sequencing reveals input-dependent area identity – Nature